386 related articles for article (PubMed ID: 26126965)
1. Humoral factors in ALS patients during disease progression.
Ehrhart J; Smith AJ; Kuzmin-Nichols N; Zesiewicz TA; Jahan I; Shytle RD; Kim SH; Sanberg CD; Vu TH; Gooch CL; Sanberg PR; Garbuzova-Davis S
J Neuroinflammation; 2015 Jun; 12():127. PubMed ID: 26126965
[TBL] [Abstract][Full Text] [Related]
2. Intraperitoneally administered IgG from patients with amyotrophic lateral sclerosis or from an immune-mediated goat model increase the levels of TNF-α, IL-6, and IL-10 in the spinal cord and serum of mice.
Obál I; Klausz G; Mándi Y; Deli M; Siklós L; Engelhardt JI
J Neuroinflammation; 2016 May; 13(1):121. PubMed ID: 27220674
[TBL] [Abstract][Full Text] [Related]
3. Neurofilament Subunit L Levels in the Cerebrospinal Fluid and Serum of Patients with Amyotrophic Lateral Sclerosis.
Gong ZY; Lv GP; Gao LN; Lu Y; Guo J; Zang DW
Neurodegener Dis; 2018; 18(2-3):165-172. PubMed ID: 29898446
[TBL] [Abstract][Full Text] [Related]
4. Elevated levels of ferritin in the cerebrospinal fluid of amyotrophic lateral sclerosis patients.
Zheng Y; Gao L; Wang D; Zang D
Acta Neurol Scand; 2017 Aug; 136(2):145-150. PubMed ID: 27804118
[TBL] [Abstract][Full Text] [Related]
5. Phosphorylated neurofilament heavy subunit (pNF-H) in peripheral blood and CSF as a potential prognostic biomarker in amyotrophic lateral sclerosis.
Boylan KB; Glass JD; Crook JE; Yang C; Thomas CS; Desaro P; Johnston A; Overstreet K; Kelly C; Polak M; Shaw G
J Neurol Neurosurg Psychiatry; 2013 Apr; 84(4):467-72. PubMed ID: 23117489
[TBL] [Abstract][Full Text] [Related]
6. Increased levels of inflammatory chemokines in amyotrophic lateral sclerosis.
Kuhle J; Lindberg RL; Regeniter A; Mehling M; Steck AJ; Kappos L; Czaplinski A
Eur J Neurol; 2009 Jun; 16(6):771-4. PubMed ID: 19236470
[TBL] [Abstract][Full Text] [Related]
7. Altered expression of metabolic proteins and adipokines in patients with amyotrophic lateral sclerosis.
Ngo ST; Steyn FJ; Huang L; Mantovani S; Pfluger CM; Woodruff TM; O'Sullivan JD; Henderson RD; McCombe PA
J Neurol Sci; 2015 Oct; 357(1-2):22-7. PubMed ID: 26198021
[TBL] [Abstract][Full Text] [Related]
8. Elevated Levels of IFN-γ in CSF and Serum of Patients with Amyotrophic Lateral Sclerosis.
Liu J; Gao L; Zang D
PLoS One; 2015; 10(9):e0136937. PubMed ID: 26332465
[TBL] [Abstract][Full Text] [Related]
9. Measurement of cystatin C levels in the cerebrospinal fluid of patients with amyotrophic lateral sclerosis.
Ren Y; Zhu W; Cui F; Yang F; Chen Z; Ling L; Huang X
Int J Clin Exp Pathol; 2015; 8(5):5419-26. PubMed ID: 26191245
[TBL] [Abstract][Full Text] [Related]
10. Reduced levels of alpha-1-antitrypsin in cerebrospinal fluid of amyotrophic lateral sclerosis patients: a novel approach for a potential treatment.
Wormser U; Mandrioli J; Vinceti M; Fini N; Sintov A; Brodsky B; Proskura E; Finkelstein Y
J Neuroinflammation; 2016 Jun; 13(1):131. PubMed ID: 27245439
[TBL] [Abstract][Full Text] [Related]
11. Vitamin D levels are associated with gross motor function in amyotrophic lateral sclerosis.
Paganoni S; Macklin EA; Karam C; Yu H; Gonterman F; Fetterman KA; Cudkowicz M; Berry J; Wills AM
Muscle Nerve; 2017 Oct; 56(4):726-731. PubMed ID: 28044349
[TBL] [Abstract][Full Text] [Related]
12. Immunoreactivity of the phosphorylated axonal neurofilament H subunit (pNF-H) in blood of ALS model rodents and ALS patients: evaluation of blood pNF-H as a potential ALS biomarker.
Boylan K; Yang C; Crook J; Overstreet K; Heckman M; Wang Y; Borchelt D; Shaw G
J Neurochem; 2009 Dec; 111(5):1182-91. PubMed ID: 19765193
[TBL] [Abstract][Full Text] [Related]
13. Biological follow-up in amyotrophic lateral sclerosis: decrease in creatinine levels and increase in ferritin levels predict poor prognosis.
Patin F; Corcia P; Madji Hounoum B; Veyrat-Durebex C; Respaud E; Piver E; Benz-de Bretagne I; Vourc'h P; Andres CR; Blasco H
Eur J Neurol; 2015 Oct; 22(10):1385-90. PubMed ID: 26095828
[TBL] [Abstract][Full Text] [Related]
14. Biomarker-based predictive models for prognosis in amyotrophic lateral sclerosis.
Su XW; Simmons Z; Mitchell RM; Kong L; Stephens HE; Connor JR
JAMA Neurol; 2013 Dec; 70(12):1505-11. PubMed ID: 24145899
[TBL] [Abstract][Full Text] [Related]
15. Evidence for peripheral immune activation in amyotrophic lateral sclerosis.
Chen X; Feng W; Huang R; Guo X; Chen Y; Zheng Z; Shang H
J Neurol Sci; 2014 Dec; 347(1-2):90-5. PubMed ID: 25312013
[TBL] [Abstract][Full Text] [Related]
16. Potential Role of Humoral IL-6 Cytokine in Mediating Pro-Inflammatory Endothelial Cell Response in Amyotrophic Lateral Sclerosis.
Garbuzova-Davis S; Ehrhart J; Sanberg PR; Borlongan CV
Int J Mol Sci; 2018 Jan; 19(2):. PubMed ID: 29385088
[TBL] [Abstract][Full Text] [Related]
17. Increased peripheral blood inflammatory cytokine levels in amyotrophic lateral sclerosis: a meta-analysis study.
Hu Y; Cao C; Qin XY; Yu Y; Yuan J; Zhao Y; Cheng Y
Sci Rep; 2017 Aug; 7(1):9094. PubMed ID: 28831083
[TBL] [Abstract][Full Text] [Related]
18. Longitudinal assessment of clinical and inflammatory markers in patients with amyotrophic lateral sclerosis.
Prado LGR; Rocha NP; de Souza LC; Bicalho ICS; Gomez RS; Vidigal-Lopes M; Braz NFT; Vieira ÉLM; Teixeira AL
J Neurol Sci; 2018 Nov; 394():69-74. PubMed ID: 30219498
[TBL] [Abstract][Full Text] [Related]
19. CSF glial markers correlate with survival in amyotrophic lateral sclerosis.
Süssmuth SD; Sperfeld AD; Hinz A; Brettschneider J; Endruhn S; Ludolph AC; Tumani H
Neurology; 2010 Mar; 74(12):982-7. PubMed ID: 20308682
[TBL] [Abstract][Full Text] [Related]
20. Increased levels of MIP-1α in CSF and serum of ALS.
Yang X; Gao L; Wu X; Zhang Y; Zang D
Acta Neurol Scand; 2016 Aug; 134(2):94-100. PubMed ID: 26427609
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
